Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

BiondVax enrols first patient in Phase lll trial of M-001

Influenza virus. Credit: Kat Masback.

Go Top